Publications View
Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.
Authors: Authors: Clish CB, Sun YP, Serhan CN.
Biochem Biophys Res Commun
View full abstract on Pubmed
Biochem Biophys Res Commun
View full abstract on Pubmed
Lipid mediator class switching during acute inflammation: signals in resolution.
Authors: Authors: Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN.
Nat Immunol
View full abstract on Pubmed
Nat Immunol
View full abstract on Pubmed
Novel antiinflammatory targets for asthma. A role for PPARgamma?
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4.
Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
Authors: Authors: Wada K, Qiu FH, Stahl GL, Serhan CN.
J Hematother Stem Cell Res
View full abstract on Pubmed
J Hematother Stem Cell Res
View full abstract on Pubmed
Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Authors: Authors: Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN.
Am J Pathol
View full abstract on Pubmed
Am J Pathol
View full abstract on Pubmed
Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.